277 related articles for article (PubMed ID: 37289211)
1. Pulmonary hypertension associated with left heart disease.
Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary hypertension associated with left heart disease (group 2)].
Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension associated with left-sided heart failure.
Adler J; Gerhardt F; Wissmüller M; Adler C; Baldus S; Rosenkranz S
Curr Opin Cardiol; 2020 Nov; 35(6):610-619. PubMed ID: 32969856
[TBL] [Abstract][Full Text] [Related]
4. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular heart failure and pulmonary hypertension.
Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary hypertension associated with left heart disease (group 2)].
Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
Lee F; Mielniczuk LM
Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.
Rosenkranz S; Lang IM; Blindt R; Bonderman D; Bruch L; Diller GP; Felgendreher R; Gerges C; Hohenforst-Schmidt W; Holt S; Jung C; Kindermann I; Kramer T; Kübler WM; Mitrovic V; Riedel A; Rieth A; Schmeisser A; Wachter R; Weil J; Opitz CF
Int J Cardiol; 2018 Dec; 272S():53-62. PubMed ID: 30527996
[TBL] [Abstract][Full Text] [Related]
11. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
[TBL] [Abstract][Full Text] [Related]
12. Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
Segovia F; Garcia H; Alkhateeb H; Mukherjee D; Nickel N
Cardiovasc Hematol Disord Drug Targets; 2023; 23(4):215-225. PubMed ID: 37921162
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
Kido K; Coons JC
Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
[TBL] [Abstract][Full Text] [Related]
14. Update in approaches to pulmonary hypertension because of left heart disease.
Kennedy JLW; Mihalek AD
Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
[TBL] [Abstract][Full Text] [Related]
16. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y
J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Huston JH; Shah SJ
Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
[TBL] [Abstract][Full Text] [Related]
18. The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.
Awada C; Boucherat O; Provencher S; Bonnet S; Potus F
Vascul Pharmacol; 2023 Aug; 151():107180. PubMed ID: 37178949
[TBL] [Abstract][Full Text] [Related]
19. [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
Rosenkranz S
Herz; 2023 Feb; 48(1):23-30. PubMed ID: 36648489
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary hypertension – a common condition in left heart disease].
Lundgren J; Rådegran G
Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
